Covetrus (CVET) Peer Comparison

$20.99

$0.00 (0.00%)

As on 14-Oct-2022 09:30EDT

Market cap

$2,941 Mln

Revenue (TTM)

$4,649 Mln

P/E Ratio

--

P/B Ratio

2

Div. Yield

0 %

Edit

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Market cap ($ Mln)	2,941	1,008	814
Revenue ($ Mln)	4,649	--	176
Net Profit ($ Mln)	-13.00	-190.16	-701.99
Net Margin (%)	-0.28	-21,707.19	-400.00
RoE (%)	-0.86	-41.66	--
Price to Earnings	--	--	--
Price-To-Book	1.95	2.31	9.54

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Operating Revenue	4,575.00	0.00	292.57
Cost of Revenue	3,717.00	--	118.81
Gross Profit	858.00	--	173.75
Operating Expenses	881.00	173.99	1,223.95
Operating Profit (EBIT)	-23.00	-173.99	-1,052.37
Other Income	1.00	1.05	--
Profit before Tax	-54.00	-172.81	-1,026.94
Provision for Tax	-7.00	0.15	-8.79
Profit after Tax (Net Income)	-54.00	-172.96	-1,018.15
Minority Interest	--	--	--
Consolidated Profit	-54.00	-172.96	-1,018.15

Liabilities ($ Mln)

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Shareholder's Funds	1,511.00	498.36	927.80
Minority Interest	--	--	--
Non-Current Liabilities	1,201.00	27.62	805.51
Current Liabilities	698.00	35.09	334.32
Total Liabilities	3,410.00	561.06	2,067.63

Assets ($ Mln)

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Non-Current Assets	2,059.00	74.66	346.03
Current Assets	1,351.00	486.40	1,721.60
Total Assets	3,410.00	561.06	2,067.63
Total Debt*	1,046.00	32.74	787.43
Net Current Assets	653.00	451.31	1,387.28

Cashflow ($ Mln)

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Cash From Operating Activities	102.00	-149.79	-1,211.97
Cash Flow from Investing Activities	-140.00	-55.38	-18.12
Cash from Financing Activities	-66.00	-0.46	1,332.75
Net Cash Inflow / Outflow	-104.00	-205.62	--

Ratios

Profitability Ratios

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
ROCE (%)	-2.09	-29.33	-67.60
ROE (%)	-3.54	-30.17	-96.74
ROA (%)	-1.56	-27.85	-51.01
EBIT Margin (%)	--	--	--
Net Margin (%)	-1.18	-16,410.25	-348.01
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Revenue Growth (%)	0.05	-1.00	-0.17
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	-184.21	-145.64	-20.24
EPS Growth (%)	-1.45	-0.20	-0.06
Book Value Growth (%)	--	--	--

Valuation Ratios

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Price / Earnings	-50.66	-3.86	-0.90
Price / Book Value	1.81	1.34	0.99
Dividend Yield (%)	--	--	--
EV/EBITDA	20.22	-1.37	-0.28
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Debt to Equity	0.69	0.07	0.85
Short term debt to equity ratio	0.02	0.01	0.02
Current Ratio	1.94	13.86	5.15
Quick Ratio	1.10	--	4.80
Interest Coverage	-0.69	--	-250.02

Operating Efficiency Ratios

	Covetrus (CVET)	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR
Debtors to sales (%)	12.13	--	37.73
Asset Turnover	1.32	0.00	0.15
Receivable days	45.07	--	76.83
Inventory Days	54.68	--	252.29
Payable days	41.62	--	190.39
Cash Conversion Cycle	58.14	--	138.73

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly